Sign in

CIK 0001636282

  • Large accelerated filer

Spyre Therapeutics, Inc.

Sign in to watch
Ticker
SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464312787
Phone
+1 617-651-5940
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aeglea BioTherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$12,349,597
in 6 filings, $12.3M under 10b5-1 plans

Net −$12,349,597. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-08-22 TYLER JOSEPH E VP, Manufacturing Grant or award · Employee Stock Option (right to buy) +25,000 25,000
2017-03-20 TYLER JOSEPH E VP, Manufacturing Grant or award · Employee Stock Option (right to buy) +39,000 39,000
2016-05-17 TYLER JOSEPH E VP, Manufacturing Grant or award · Employee Stock Option (right to buy) +33,000 33,000
2016-04-12 TYLER JOSEPH E VP, Manufacturing Conversion +31,260 42,428
2016-04-12 TYLER JOSEPH E VP, Manufacturing Conversion · Series A Preferred Stock −22,857 0
2016-04-12 TYLER JOSEPH E VP, Manufacturing Conversion · Series B Preferred Stock −8,403 0

Page 1 of 1 · 6 trades